The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C (Q73838437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

S M McKiernan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R Hagan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Curry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G S McDonald

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

N Nolan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Crowley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Hegarty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Lawlor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Kelleher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1124-1130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of Hepatitis C in the West

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Clinical outcomes after transfusion-associated hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

MHC class II genes influence the susceptibility to chronic active hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

HLA antigens in patients with chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Histological grading and staging of chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

HLA and disease associations: detecting the strongest association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Hepatitis C virus liver disease in women infected with contaminated anti-D immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

X-Ray Crystal Structure of HLA-DR4 (DRA*0101, DRB1*0401) Complexed with a Peptide from Human Collagen II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970365-9

10.1016/S0016-5085(00)70365-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10833487%20AND%20SRC:MED&resulttype=core&format=json